NCT02451579View on ClinicalTrials.gov

A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Actinic Keratoses
Interventions
DRUG

Antihistamine Cetirizine Hydrochloride

Prophylactic use of antihistamine prior to and following topical 5-aminolevulonic acid photodynamic therapy

OTHER

Placebo

Use of placebo prior to and following topical 5-aminolevulonic acid photodynamic therapy

Trial Locations (1)

92121

Cosmetic Laser Dermatology, San Diego

Sponsors
All Listed Sponsors
collaborator

DUSA Pharmaceuticals, Inc.

INDUSTRY

lead

Goldman, Butterwick, Fitzpatrick and Groff

OTHER